ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: However, even chronic phase CML cannot be eradicated by TKI because BCR-ABL-transformed cells in the stem cell compartment are not addicted to BCR-ABL kinase for survival [3, 17–21].